236 related articles for article (PubMed ID: 16601289)
21. Role of protein kinase C in facilitation of luteinizing hormone (LH)-releasing hormone-induced LH surges by neuropeptide Y.
Leupen SM; Levine JE
Endocrinology; 1999 Aug; 140(8):3682-7. PubMed ID: 10433227
[TBL] [Abstract][Full Text] [Related]
22. Dependence of gonadotropin-releasing hormone-induced neuronal MAPK signaling on epidermal growth factor receptor transactivation.
Shah BH; Soh JW; Catt KJ
J Biol Chem; 2003 Jan; 278(5):2866-75. PubMed ID: 12446705
[TBL] [Abstract][Full Text] [Related]
23. GnRH activates ERK1/2 leading to the induction of c-fos and LHbeta protein expression in LbetaT2 cells.
Liu F; Austin DA; Mellon PL; Olefsky JM; Webster NJ
Mol Endocrinol; 2002 Mar; 16(3):419-34. PubMed ID: 11875099
[TBL] [Abstract][Full Text] [Related]
24. Antiproliferative signaling of luteinizing hormone-releasing hormone in human endometrial and ovarian cancer cells through G protein alpha(I)-mediated activation of phosphotyrosine phosphatase.
Gründker C; Völker P; Emons G
Endocrinology; 2001 Jun; 142(6):2369-80. PubMed ID: 11356684
[TBL] [Abstract][Full Text] [Related]
25. Stimulation of mitogen-activated protein kinase by gonadotropin-releasing hormone: evidence for the involvement of protein kinase C.
Sundaresan S; Colin IM; Pestell RG; Jameson JL
Endocrinology; 1996 Jan; 137(1):304-11. PubMed ID: 8536629
[TBL] [Abstract][Full Text] [Related]
26. Mechanism of mitogen-activated protein kinase activation by gonadotropin-releasing hormone in the pituitary of alphaT3-1 cell line: differential roles of calcium and protein kinase C.
Reiss N; Llevi LN; Shacham S; Harris D; Seger R; Naor Z
Endocrinology; 1997 Apr; 138(4):1673-82. PubMed ID: 9075730
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of T lymphocyte activation by cAMP is associated with down-regulation of two parallel mitogen-activated protein kinase pathways, the extracellular signal-related kinase and c-Jun N-terminal kinase.
Tamir A; Granot Y; Isakov N
J Immunol; 1996 Aug; 157(4):1514-22. PubMed ID: 8759733
[TBL] [Abstract][Full Text] [Related]
28. Analogs of GnRH-I and GnRH-II inhibit epidermal growth factor-induced signal transduction and resensitize resistant human breast cancer cells to 4OH-tamoxifen.
Günthert AR; Gründker C; Olota A; Läsche J; Eicke N; Emons G
Eur J Endocrinol; 2005 Oct; 153(4):613-25. PubMed ID: 16189183
[TBL] [Abstract][Full Text] [Related]
29. Promotion of human trophoblasts invasion by gonadotropin-releasing hormone (GnRH) I and GnRH II via distinct signaling pathways.
Liu J; Maccalman CD; Wang YL; Leung PC
Mol Endocrinol; 2009 Jul; 23(7):1014-21. PubMed ID: 19372239
[TBL] [Abstract][Full Text] [Related]
30. ErbB4 cleavage by gonadotropin-releasing hormone receptor stimulation in cultured gonadotroph cells.
Omoto Y; Higa-Nakamine S; Higa A; Yamamoto H
Eur J Pharmacol; 2017 Mar; 799():171-179. PubMed ID: 28167260
[TBL] [Abstract][Full Text] [Related]
31. Transcriptional activation of the ovine follicle-stimulating hormone-beta gene by gonadotropin-releasing hormone involves multiple signal transduction pathways.
Vasilyev VV; Pernasetti F; Rosenberg SB; Barsoum MJ; Austin DA; Webster NJ; Mellon PL
Endocrinology; 2002 May; 143(5):1651-9. PubMed ID: 11956146
[TBL] [Abstract][Full Text] [Related]
32. Gonadotropin-releasing hormone activates the equine luteinizing hormone beta promoter through a protein kinase C/mitogen-activated protein kinase pathway.
Call GB; Wolfe MW
Biol Reprod; 1999 Sep; 61(3):715-23. PubMed ID: 10456849
[TBL] [Abstract][Full Text] [Related]
33. CGP 41251 and tamoxifen selectively inhibit mitogen-activated protein kinase activation and c-Fos phosphoprotein induction by substance P in human astrocytoma cells.
Luo W; Sharif TR; Houghton PJ; Sharif M
Cell Growth Differ; 1997 Nov; 8(11):1225-40. PubMed ID: 9372245
[TBL] [Abstract][Full Text] [Related]
34. Autocrine role of gonadotropin-releasing hormone and its receptor in ovarian cancer cell growth.
Kang SK; Cheng KW; Nathwani PS; Choi KC; Leung PC
Endocrine; 2000 Dec; 13(3):297-304. PubMed ID: 11216641
[TBL] [Abstract][Full Text] [Related]
35. Gonadotropin-releasing hormone type II antagonists induce apoptotic cell death in human endometrial and ovarian cancer cells in vitro and in vivo.
Fister S; Günthert AR; Emons G; Gründker C
Cancer Res; 2007 Feb; 67(4):1750-6. PubMed ID: 17308117
[TBL] [Abstract][Full Text] [Related]
36. Gonadotropin-releasing hormone receptor activation of extracellular signal-regulated kinase and tyrosine kinases in transfected GH3 cells and in alphaT3-1 cells.
Johnson MS; Lutz EM; MacKenzie CJ; Wolbers WB; Robertson DN; Holland PJ; Mitchell R
Endocrinology; 2000 Sep; 141(9):3087-97. PubMed ID: 10965878
[TBL] [Abstract][Full Text] [Related]
37. GnRH receptor signaling in tilapia pituitary cells: role of mitogen-activated protein kinase (MAPK).
Gur G; Bonfil D; Safarian H; Naor Z; Yaron Z
Comp Biochem Physiol B Biochem Mol Biol; 2001 Jun; 129(2-3):517-24. PubMed ID: 11399487
[TBL] [Abstract][Full Text] [Related]
38. In vitro action of testosterone in potentiating gonadotropin-releasing hormone-stimulated gonadotropin-II secretion in goldfish pituitary cells: involvement of protein kinase C, calcium, and testosterone metabolites.
Lo A; Chang JP
Gen Comp Endocrinol; 1998 Sep; 111(3):318-33. PubMed ID: 9707478
[TBL] [Abstract][Full Text] [Related]
39. Gonadotropin-releasing hormone-desensitized LbetaT2 gonadotrope cells are refractory to acute protein kinase C, cyclic AMP, and calcium-dependent signaling.
Liu F; Austin DA; Webster NJ
Endocrinology; 2003 Oct; 144(10):4354-65. PubMed ID: 12960037
[TBL] [Abstract][Full Text] [Related]
40. Gonadotropin-releasing hormone-II increases membrane type I metalloproteinase production via beta-catenin signaling in ovarian cancer cells.
Ling Poon S; Lau MT; Hammond GL; Leung PC
Endocrinology; 2011 Mar; 152(3):764-72. PubMed ID: 21239435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
